Trade Mark Journal No.2026/007 13 February 2026
WO0000001899044 (5)
Office of origin: United States of America
Date of International Registration:18 December 2025
Date of designation in the UK:
18 December 2025

International priority date claimed: 26 June 2025
(United States of America)
(99254091)
- Class 5
- Pharmaceutical preparations for the treatment of diseases or conditions mediated by a c-kit or mutant c-kit protein kinase.
Cogent Biosciences, Inc.
Representative: Gabriel M. Gillmeyer Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston MA 02199, UNITED STATES OF AMERICA